Whole-Genome Sequencing (WGS)

Whole exome sequencing solutions

Accelerate genetic discovery with OHMX.bio’s Whole Exome Sequencing (WES) services. By focusing on the protein-coding regions of the genome, WES provides a cost-effective and highly efficient approach to identifying disease-associated variants.
Contact us

What is whole exome sequencing?

Whole Exome Sequencing (WES) is a next-generation sequencing (NGS) technique that selectively captures and sequences only the exonic regions of the genome, which contain approximately 85% of known disease-causing mutations. This targeted approach allows researchers to efficiently detect genetic variations linked to inherited disorders, cancer, and other diseases while minimizing sequencing costs and data complexity compared to Whole Genome Sequencing (WGS).
Contact us

Key advantages of whole exome sequencing (WES)

Cost-Effective

Provides deep sequencing coverage of clinically relevant regions at a lower cost than WGS.

Efficient Variant Detection

Focuses on functionally significant mutations in protein-coding genes.

Reduced Data Burden

Generates manageable datasets for streamlined analysis and interpretation.

Combine our WES pipeline with our Element Biosciences AVITI sequencer with higher read-accuracy for a more detailed variant analysis without increasing cost.
Contact us

Applications of whole exome sequencing

WES is widely used for:

Genetic Disease Research

Identify pathogenic mutations driving inherited disorders.

Oncology & Tumor Profiling

Detect somatic and germline mutations linked to cancer.

Translational Medicine

Support biomarker discovery and personalized treatment strategies.

Contact us

Let’s get in touch!

Are you curious about how we can work on your -omics challenges together? Fill out the form below!
Our experts will reply within 2 working days to freely discuss your omics project.

Our publications using our WES services

  1. Iyer, Shruti V., Sara Goodwin, and William Richard McCombie. “Leveraging the power of long reads for targeted sequencing.” Genome Research 34.11 (2024): 1701-1718.